fbpx

15th Annual Congress on Controversies in Ophthalmology (COPHy 2024)

Find Out More

Feb 6, 2024

FDA warns consumers of contaminated copycat eye drops

 

 

by, David Hutton, Managing Editor, Ophthalmology Times

In a news release, the FDA noted these are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief.

The FDA has issued a warning to consumers not to purchase or use South Moon, Rebright, or FivFivGo eye drops because of the potential risk of eye infection.

According to an FDA news release,1 the drops in question are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief.

The FDA noted in its news release that the South Moon, Rebright and FivFivGo eye drops are unapproved drugs and should not be available for sale in the US. The makers claim the drops can treat several eye conditions, including glaucoma, which is treated with prescription drugs or surgery.

Moreover, the FDA noted that patients who have the signs or symptoms of an eye infection should talk to their healthcare provider or seek medical care immediately. FDA recommends consumers should get rid of the products in an appropriate manner.

Read: https://www.optometrytimes.com/view/fda-warns-consumers-of-contaminated-copycat-eye-drops?

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.